More Hedge Funds Launch in April-June Period, After First-Quarter 12-Year Low (Reuters)
LONDON (Reuters) – A total of 129 new hedge funds launched in the April-June quarter this year, recovering from the previous quarter’s 12-year low as investor confidence slowly recovered from the COVID-19 hit, according to industry tracker Hedge Fund Research. The second-quarter number was the highest since the year-ago period when 153 hedge funds started trading, HFR said in a report on Wednesday.
Paamco Offering Pools Manager Exposures (Green Street)
Paamco Prisma is planning another hedge fund product. The offering follows a format in which managers of multiple portfolios run money separately under a single master-feeder umbrella, in this case called Molecule. Managers that aren’t affiliated with Paamco trade most of the sub-accounts, which span asset classes in the U.S. and abroad but are heavy on long/short or relative-value equity strategies. Discretionary trading teams within Paamco also manage some of the portfolios.
Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $8.3 million of Shares (Guru Focus)
Chairman, President and COO of Guardant Health Inc., Amirali Talasaz, sold 75,000 shares of GH on 09/25/2020 at an average price of $110.71 a share. The total sale was $8.3 million. Guardant Health Inc has a market cap of $11.06 billion; its shares were traded at around $111.24 with and P/S ratio of 40.82. GuruFocus has detected 1 severe warning sign with Guardant Health Inc.
Wednesday 9/30 Insider Buying Report: AGEN, JMP (Nasdaq.com)
At Agenus (AGEN), a filing with the SEC revealed that on Friday, CEO Garo H. Armen purchased 100,000 shares of AGEN, at a cost of $5.03 each, for a total investment of $503,000. Bargain hunters have the opportunity to snag AGEN at a price even lower than Armen did, with the stock changing hands as low as $4.62 in trading on Wednesday which is 8.2% below Armen’s purchase price. Agenus is trading up about 4.7% on the day Wednesday. This buy marks the first one filed by Armen in the past year. And also on Friday, CEO Joseph A. Jolson purchased $494,532 worth of JMP Group (JMP), purchasing 80,002 shares at a cost of $6.18 a piece. Before this latest buy, Jolson purchased JMP at 3 other times during the past year, for a total investment of $6.89M at an average of $6.81 per share. JMP Group is trading up about 0.8% on the day Wednesday. Jolson was up about 3.7% on the purchase at the high point of today’s trading session, with JMP trading as high as $6.41 in trading on Wednesday.
Walmart (NYSE: WMT) Executives are Making Moves with Their Shares (Analyst Ratings)
Yesterday, a Major Shareholder at Walmart (WMT), Jim Walton, sold shares of WMT for $103.2M. Following Jim Walton’s last WMT Sell transaction on June 07, 2019, the stock climbed by 33.4%. In addition to Jim Walton, 2 other WMT executives reported Sell trades in the last month. Based on Walmart’s latest earnings report for the quarter ending July 31, the company posted quarterly revenue of $138 billion and quarterly net profit of $6.48 billion.
Edwards Lifesciences Corp (EW) Chairman & CEO Michael A Mussallem Sold $5.4 million of Shares (Guru Focus)
Chairman & CEO of Edwards Lifesciences Corp., Michael A Mussallem, sold 68,550 shares of EW on 09/29/2020 at an average price of $78.74 a share. The total sale was $5.4 million. Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease.
